Price (delayed)

$23.13

Market cap

$1.08B

P/E Ratio

45.35

Dividend/share

$0.04

EPS

$0.51

Enterprise value

$1.3B

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70

CLB's net income has soared by 144% year-on-year and by 22% since the previous quarter

Core Laboratories N V's EPS has soared by 143% YoY and by 21% from the previous quarter

CLB's debt is up by 6% from the previous quarter but it is down by 6% YoY

What are the main financial stats of CLB

Market
Valuations
Earnings

Shares outstanding

46.66M

Market cap

$1.08B

Enterprise value

$1.3B

Price to earnings (P/E)

45.35

Price to book (P/B)

5.52

Price to sales (P/S)

2.15

EV/EBIT

26.95

EV/EBITDA

20.03

EV/Sales

2.58

Revenue

$502.79M

EBIT

$48.17M

EBITDA

$64.82M

Free cash flow

$8.33M

Per share
Balance sheet
Liquidity

EPS

$0.51

Free cash flow per share

$0.18

Book value per share

$4.19

Revenue per share

$10.78

TBVPS

$10.44

Total assets

$593.62M

Total liabilities

$393.47M

Debt

$235.31M

Equity

$195.39M

Working capital

$132.3M

Debt to equity

1.2

Current ratio

2.38

Quick ratio

1.33

Net debt/EBITDA

3.38

Margins
Efficiency
Dividend

EBITDA margin

12.9%

Gross margin

20.8%

Net margin

4.7%

Operating margin

9.6%

Return on assets

4.1%

Return on equity

13%

Return on invested capital

8.1%

Return on capital employed

9.7%

Return on sales

9.6%

Dividend yield

0.17%

DPS

$0.04

Payout ratio

7.8%

How has the Core Laboratories N V stock price performed over time

Intraday

1.14%

1 week

6.15%

1 month

10.94%

1 year

-13.98%

YTD

14.11%

QTD

4.9%

How have Core Laboratories N V's revenue and profit performed over time

Revenue

$502.79M

Gross profit

$104.56M

Operating income

$48.4M

Net income

$23.71M

Gross margin

20.8%

Net margin

4.7%

CLB's net income has soared by 144% year-on-year and by 22% since the previous quarter

CLB's net margin has soared by 135% YoY and by 18% from the previous quarter

Core Laboratories N V's operating income has increased by 46% YoY and by 17% QoQ

The operating margin has increased by 37% YoY and by 13% from the previous quarter

What is Core Laboratories N V's growth rate over time

What is Core Laboratories N V stock price valuation

P/E

45.35

P/B

5.52

P/S

2.15

EV/EBIT

26.95

EV/EBITDA

20.03

EV/Sales

2.58

Core Laboratories N V's EPS has soared by 143% YoY and by 21% from the previous quarter

The stock's price to earnings (P/E) is 23% less than its last 4 quarters average of 59.2 and 14% less than its 5-year quarterly average of 52.8

The P/B is 55% below the 5-year quarterly average of 12.4 but 15% above the last 4 quarters average of 4.8

CLB's equity is up by 21% YoY and by 6% from the previous quarter

CLB's price to sales (P/S) is 28% lower than its 5-year quarterly average of 3.0 but 19% higher than its last 4 quarters average of 1.8

The company's revenue rose by 5% YoY and by 2.7% QoQ

How efficient is Core Laboratories N V business performance

The ROA has soared by 141% YoY and by 21% from the previous quarter

The return on equity has surged by 110% year-on-year and by 16% since the previous quarter

The return on invested capital has surged by 53% year-on-year and by 17% since the previous quarter

Core Laboratories N V's ROS has increased by 39% YoY and by 14% from the previous quarter

What is CLB's dividend history

DPS

$0.04

Dividend yield

0.17%

Payout ratio

7.8%

Recent dividends

How did Core Laboratories N V financials performed over time

The total assets is 51% greater than the total liabilities

CLB's current ratio is up by 17% year-on-year and by 16% since the previous quarter

The quick ratio has increased by 12% QoQ and by 10% YoY

CLB's debt is 20% more than its equity

The debt to equity has decreased by 22% YoY

CLB's equity is up by 21% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.